Home  >  TopNews
Policy & Regulations
+ Font Resize -

Kerala drugs control dept initiates legal action against Jan Aushadhi store for selling branded drugs

Peethaambaran Kunnathoor, Chennai
Tuesday, November 21, 2017, 08:00 Hrs  [IST]

Kerala drugs control department has taken legal action against a Jan Aushadhi medical store in Thiruvananthapuram for not complying with provisions of Drugs & Cosmetics Act by selling drugs failing in quality tests. Many of the total 306 JAS outlets are found to be pushing branded medicines of major pharma companies instead of selling only generic drugs, according to Revi S Menon, DC-in-charge, Kerala.

The drug inspector at Vanchiyur in the capital city, Maniveena, conducted an inspection in a Jan Aushadhi retail outlet functioning near general hospital, following a complaint she received from two law students.

The students’ complaint was that the pharmacist at the medical store did not dispense the drug prescribed by the doctor and he gave a branded product of the same molecule at the MRP rate printed on it. But the drug inspector was unable to take action against this category change, instead she verified the registers and found that the Jan Aushadhi medical store was not keeping purchase registers for generic as well as for the branded products he kept at the store.

She said the drug dispensed to the law students was Zinetac, a ranitidine drug, but the prescription was for Rantac. Zinetac was sold to the students on the MRP rate, though they wanted 20 per cent discount. Drugs are supplied to JAS outlets by BPPI (Bureau of Pharma PSUs of India) sources. It was found that the medical store at Vanchiyur was purchasing branded medicines from outside and selling it through JAS outlets on MRP rates without maintaining proper records.

To a query, the drug inspector said the medical store was selling several other medicines without keeping proper registers. Against this violation of drugs laws, the drug inspector initiated action against the illegal sale and seized a huge quantity of various categories of medicines. A case was filed under Section 18 A with the First Class Magistrate Court at Vanchiyur.

The state drugs controller said there are two more cases against Jan Aushadhi stores, reported from Thrissur district. He said a sample drawn from a JA store in Thrissur failed in the quality test. When Pharmabiz raised this issue to the CEO of the BPPI, he said whenever a complaint of quality failure reported from any part of the country, soon the contract with the supplier of that drug will be cancelled.

Regarding shortage of medicines for lifestyle disease in Jan Aushadhi stores, Biplab Chatterjee, the CEO, said supply chain will be streamlined in Kerala very shortly for the people to avail all quality drugs at reasonable rates as Kerala is the number two state with largest number of JAS outlets in India. UP stands first with 450 outlets.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
Abraham Chandy John Nov 21, 2017 3:11 PM
The report heading is baseless. No Jan Aushadhi storem will sell prohibited medicine.The doctors have been given strict instruction to make the prescriptions with generic names of the medicines instead branded items. Why this mistake done by Doctors are not highlighted? All JAS have drug licence and the store is to be maintained and operated as per drug Controller"s instructions inforce and the BPPI has allowed them to sell medicines that are not marketed through BPPI. There is no difference in the licence of Jan Aushadhi as well as other medicine retail shops. It is doubted that the present report is mutilated to suit the private medical stores who sell the items at MRP. The branded medicines are supplied to a distributor upto 80% discounted rate. Even then, a patient is to bear 100% while purchasing from a private medical store. Can you take any measure to cut down the rates to the tune of factory billing to the CIF Agency or Distributor? Can you impress the Central Govt to ban GST
 
PITS_2017
duphat_150x60
Pre-Connect Congress 2017
acssymposium
PHARMACONNECT_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |